Ronald A Panganiban1, Maoyun Sun1, Amber Dahlin2, Hae-Ryung Park1, Mengyuan Kan3, Blanca E Himes3, Jennifer A Mitchel1, Carlos Iribarren4, Eric Jorgenson4, Scott H Randell5, Elliot Israel6, Kelan Tantisira2, Stephanie Shore1, Jin-Ah Park1, Scott T Weiss2, Ann Chen Wu7, Quan Lu8. 1. Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health and Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Mass. 2. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. 3. Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Division of Research, Kaiser Permanente Northern California, Oakland, Calif. 5. Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina, Chapel Hill, NC. 6. Asthma Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. 7. Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass; Precision Medicine Translational Research Center, Department of Population Medicine, Harvard Medical School, Boston, Mass. 8. Program in Molecular and Integrative Physiological Sciences, Departments of Environmental Health and Genetics & Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, Mass. Electronic address: qlu@hsph.harvard.edu.
Abstract
BACKGROUND: Genetic variants in the chromosomal region 17q21 are consistently associated with asthma. However, mechanistic studies have not yet linked any of the associated variants to a function that could influence asthma, and as a result, the identity of the asthma gene(s) remains elusive. OBJECTIVES: We sought to identify and characterize functional variants in the 17q21 locus. METHODS: We used the Exome Aggregation Consortium browser to identify coding (amino acid-changing) variants in the 17q21 locus. We obtained asthma association measures for these variants in both the Genetic Epidemiology Research in Adult Health and Aging (GERA) cohort (16,274 cases and 38,269 matched controls) and the EVE Consortium study (5,303 asthma cases and 12,560 individuals). Gene expression and protein localization were determined by quantitative RT-PCR and fluorescence immunostaining, respectively. Molecular and cellular studies were performed to determine the functional effects of coding variants. RESULTS: Two coding variants (rs2305480 and rs11078928) of the gasdermin B (GSDMB) gene in the 17q21 locus were associated with lower asthma risk in both GERA (odds ratio, 0.92; P = 1.01 × 10-6) and EVE (odds ratio, 0.85; joint PEVE = 1.31 × 10-13). In GERA, rs11078928 had a minor allele frequency (MAF) of 0.45 in unaffected (nonasthmatic) controls and 0.43 in asthma cases. For European Americans in EVE, the MAF of rs2305480 was 0.45 for controls and 0.39 for cases; for all EVE subjects, the MAF was 0.32 for controls and 0.27 for cases. GSDMB is highly expressed in differentiated airway epithelial cells, including the ciliated cells. We found that, when the GSDMB protein is cleaved by inflammatory caspase-1 to release its N-terminal fragment, potent pyroptotic cell death is induced. The splice variant rs11078928 deletes the entire exon 6, which encodes 13 amino acids in the critical N-terminus, and abolishes the pyroptotic activity of the GSDMB protein. CONCLUSIONS: Our study identified a functional asthma variant in the GSDMB gene of the 17q21 locus and implicates GSDMB-mediated epithelial cell pyroptosis in pathogenesis.
BACKGROUND: Genetic variants in the chromosomal region 17q21 are consistently associated with asthma. However, mechanistic studies have not yet linked any of the associated variants to a function that could influence asthma, and as a result, the identity of the asthma gene(s) remains elusive. OBJECTIVES: We sought to identify and characterize functional variants in the 17q21 locus. METHODS: We used the Exome Aggregation Consortium browser to identify coding (amino acid-changing) variants in the 17q21 locus. We obtained asthma association measures for these variants in both the Genetic Epidemiology Research in Adult Health and Aging (GERA) cohort (16,274 cases and 38,269 matched controls) and the EVE Consortium study (5,303 asthma cases and 12,560 individuals). Gene expression and protein localization were determined by quantitative RT-PCR and fluorescence immunostaining, respectively. Molecular and cellular studies were performed to determine the functional effects of coding variants. RESULTS: Two coding variants (rs2305480 and rs11078928) of the gasdermin B (GSDMB) gene in the 17q21 locus were associated with lower asthma risk in both GERA (odds ratio, 0.92; P = 1.01 × 10-6) and EVE (odds ratio, 0.85; joint PEVE = 1.31 × 10-13). In GERA, rs11078928 had a minor allele frequency (MAF) of 0.45 in unaffected (nonasthmatic) controls and 0.43 in asthma cases. For European Americans in EVE, the MAF of rs2305480 was 0.45 for controls and 0.39 for cases; for all EVE subjects, the MAF was 0.32 for controls and 0.27 for cases. GSDMB is highly expressed in differentiated airway epithelial cells, including the ciliated cells. We found that, when the GSDMB protein is cleaved by inflammatory caspase-1 to release its N-terminal fragment, potent pyroptotic cell death is induced. The splice variant rs11078928 deletes the entire exon 6, which encodes 13 amino acids in the critical N-terminus, and abolishes the pyroptotic activity of the GSDMB protein. CONCLUSIONS: Our study identified a functional asthma variant in the GSDMB gene of the 17q21 locus and implicates GSDMB-mediated epithelial cell pyroptosis in pathogenesis.
Authors: Kwon-Sik Park; James M Wells; Aaron M Zorn; Susan E Wert; Victor E Laubach; Lucas G Fernandez; Jeffrey A Whitsett Journal: Am J Respir Cell Mol Biol Date: 2005-10-20 Impact factor: 6.914
Authors: Néomi S Grotenboer; Maria E Ketelaar; Gerard H Koppelman; Martijn C Nawijn Journal: J Allergy Clin Immunol Date: 2013-02-04 Impact factor: 10.793
Authors: Jamie R J Inshaw; Antony J Cutler; Daniel J M Crouch; Linda S Wicker; John A Todd Journal: Diabetes Care Date: 2019-09-26 Impact factor: 19.112
Authors: Hongsheng Gui; Albert M Levin; Donglei Hu; Patrick Sleiman; Shujie Xiao; Angel C Y Mak; Mao Yang; Andrea J Barczak; Scott Huntsman; Celeste Eng; Samantha Hochstadt; Ellen Zhang; Kyle Whitehouse; Samantha Simons; Whitney Cabral; Sami Takriti; Gonçalo Abecasis; Thomas W Blackwell; Hyun Min Kang; Deborah A Nickerson; Soren Germer; David E Lanfear; Frank Gilliland; W James Gauderman; Rajesh Kumar; David J Erle; Fernando D Martinez; Hakon Hakonarson; Esteban G Burchard; L Keoki Williams Journal: Am J Respir Crit Care Med Date: 2021-02-15 Impact factor: 21.405